New Pilot Study Opportunity with the AHA's Cardiogenic Shock Registry

Mechanical Circulatory Support (MCS) is a burgeoning treatment for patients with cardiogenic shock; however, there are mixed clinical outcomes with its use in prior studies with possible heterogeneity across devices and settings. Potential benefits from hemodynamic stabilization are balanced against risks of therapy, including bleeding. Mitigation of the complications of MCS is a central goal for use of all forms of MCS in order to maximize that balance toward the potential benefits. Additional research is needed to optimize outcomes with MCS within the context of a registry that holds promise for better, faster, less costly accumulation of data. However, there is a need to evaluate the robustness of safety data collected through the registry. This proposed pilot will build upon the existing evidence base, while legitimizing safety data collected by the registry for future studies that hold promise to impact the future direction of clinical practice.